Ebitda Lave om Dato
AbbVie USD 6.92B 258M 2024-12
Acadia Pharmaceuticals USD 12.2M 22.01M 2024-12
Agios Pharmaceuticals USD -105351000 18.32M 2025-03
Alnylam Pharmaceuticals USD 32.48M 123.47M 2025-03
Amgen USD 3.75B 42M 2025-03
Arrowhead Research USD -156177000 1M 2024-12
Biogen USD 754.8M 7.2M 2024-12
BioMarin Pharmaceutical USD 245.96M 51.11M 2025-03
Bristol-Myers Squibb USD 4.9B 16M 2025-03
Gilead Sciences USD 3.21B 651M 2024-12
Incyte USD 222.66M 97.54M 2025-03
Insmed USD -241795000 46.45M 2024-12
Ionis Pharmaceuticals USD -141463000 35.91M 2025-03
J&J USD 7.88B 1.76B 2025-03
Merck USD 7.12B 1.06B 2024-12
Moderna USD -924000000 69M 2025-03
Neurocrine Biosciences USD 152.1M 39.2M 2024-12
Novartis USD 5.19B 319M 2024-12
Pfizer USD 6.21B 1.5B 2025-03
PTC Therapeutics USD 1.07M 47.25M 2024-12
Regeneron Pharmaceuticals USD 730.9M 324.8M 2025-03
Roche Holding CHF 12.68B 2.36B 2024-06
Sanofi EUR 2.86B 2.3B 2025-03
Sarepta Therapeutics USD 182.21M 150.21M 2024-12
Ultragenyx Pharmaceutical USD -113199000 10.03M 2024-12
United Therapeutics USD 402.6M 19.2M 2025-03
Vertex Pharmaceuticals USD 1.16B 24.5M 2024-12



Vertex Pharmaceuticals - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - May 2025.